ETHRA Pharmaceuticals expands GMP-compliant production at its 3,000m² Addis Ababa facility to increase output of tablets, capsules, liquids, and APIs for Ethiopia and export markets.
Read article →ETHRA commissions a high-speed tablet compression line at its Addis Ababa plant, increasing solid oral dosage capacity for antibiotics, analgesics, and cardiovascular medicines.
Read article →ETHRA expands paracetamol oral suspension manufacturing to meet growing pediatric demand, producing child-safe formulations at its Addis Ababa liquid dosage facility.
Read article →ETHRA strengthens active pharmaceutical ingredient (API) manufacturing at its Addis Ababa site, improving supply security for finished dosage forms and regional partners.
Read article →ETHRA's QC laboratory expands analytical testing scope for raw materials and finished products, reinforcing GMP compliance across all manufacturing lines in Addis Ababa.
Read article →ETHRA upgrades blister packing and labelling lines to meet export-ready standards, supporting regional distribution of Ethiopian-made pharmaceutical products.
Read article →ETHRA integrates energy efficiency, waste reduction, and responsible sourcing into its Addis Ababa pharmaceutical manufacturing operations.
Read article →ETHRA's Addis Ababa facility is designed and operated to WHO GMP principles, ensuring pharmaceutical products meet international quality and safety expectations.
Read article →
